Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Iron chelation in 1998]

M de Montalembert1

  • 1Etablissement de transfusion sanguine de l'AP-HP, Paris, France.

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|December 4, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of hydroxyurea exposure before puberty on sperm parameters in males with sickle cell disease.

Blood·2020
Same author

Vaso-occlusive crisis of the temporo-mandibular joint: An unusual finding in sickle cell disease.

Journal of stomatology, oral and maxillofacial surgery·2020
Same author

Transfusing children with hemoglobinopathies.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2019
Same author

Management of iron overload in hemoglobinopathies.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2017
Same author

Time perception of simultaneous and sequential events in early-onset schizophrenia.

Neurocase·2016
Same author

[Time perception and schizophrenia: Phenomenological and neuropsychological approach].

L'Encephale·2016
Same journal

Catastrophic CD34+ autologous hematopoietic stem cell collection despite sustained mobilization and solutions to rescue the harvests.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Title of the study: Corrected Count Increment as a Predictor of Early Graft Dysfunction and Mortality Following Living Donor Liver Transplantation.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

TLR4/MD-2 complex promotes transfusion-related acute lung injury pathogenesis through the activation of the AP-1 and NF-κB signaling pathways.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

The Strategic Utility of Cryopreserved Platelets in Outer Space.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Genotyping of Human Neutrophil Antigen-3 by High Resolution Melting Analysis in Southern Thai Blood Donors.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Transfusion rate and risk factors in hemiarthroplasty of hip: A nationwide cohort study.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
See all related articles

Chronic transfusion patients need iron chelation therapy to prevent organ damage. While Desferal is effective, its infusion method poses compliance challenges, driving the search for oral alternatives like L1, despite its lower efficacy and potential side effects.

Area of Science:

  • Hematology
  • Pharmacology
  • Toxicology

Background:

  • Chronic transfusion therapy is essential for managing certain anemias but leads to iron overload.
  • Iron overload causes progressive organ damage and reduces patient life expectancy.
  • Iron chelation therapy is crucial for mitigating iron toxicity in multiply-transfused patients.

Purpose of the Study:

  • To review the challenges associated with current iron chelation therapies.
  • To discuss the development and limitations of oral iron chelators as alternatives to infusion-based treatments.

Main Methods:

  • Literature review of iron overload management in chronic transfusion regimens.
  • Comparative analysis of iron chelating agents, focusing on Desferal and L1.
  • Evaluation of administration routes, efficacy, and safety profiles.

Related Experiment Videos

Main Results:

  • Desferal remains the most efficacious iron chelator but requires lengthy subcutaneous infusions, impacting patient compliance.
  • Oral iron chelator L1 offers a more convenient administration route but demonstrates lower efficacy and carries a risk of agranulocytosis.
  • The clinical indications for L1 require further discussion and evaluation.

Conclusions:

  • Effective iron chelation is vital for patients undergoing chronic transfusions.
  • Compliance issues with Desferal necessitate the development of orally active iron chelators.
  • L1 presents a potential oral alternative, but its efficacy and safety profile require careful consideration and further research.